Continuation of Uppsala Berzelii Technology Centre for Neurodiagnostics
| Reference number | |
| Coordinator | Uppsala universitet - Institutionen för teknikvetenskaper |
| Funding from Vinnova | SEK 33 250 000 |
| Project duration | January 2010 - December 2012 |
| Status | Completed |
Purpose and goal
The aim of Uppsala Berzelii Technology Centre for Neurodiagnostics is to obtain a deeper understanding of neurodegenerative diseases. More specifically the researchers within the Centre are working on developing more sensitive analysis methods which might be used for performing early diagnosis, monitor a disease or to aid the drug discovery process. The main diseases the Centre is focusing on are Alzheimer´s disease and chronic pain. The objective of the Centre is to find new protein biomarkers that are related to Alzheimer´s disease and chronic pain. These markers could be used for industry to develop new and better medical analysis equipment, aid medical doctors to provide the correct diagnosis and support pharma industry to faster develop new and better therapeutic drugs.
Results and expected effects
We expect the Centre to create added value by allowing medical doctors interact closely with researchers who are developing new types of analysis methods. This added values will be created by having hospital and pharma industry initiate relevant topics and challenges steeming from the needs of today´s and tomorrow´s health care system. Researchers (both from academia and industry) then will have the work to develop new analysis methods and technical solutions which can be utilised for obtaining and deeper understanding of Alzheimer´s disease and chronic pain. Results that will achieved are besides scientific journals and PhDs also new medical analysis equipment and a better health care system for early diagnosis of neurodegenerative diseases.
Approach and implementation
The Centre is organised by consisting of a board, an international scientific advisory board, researcher leaders and project leaders. All these have their separate meeting to discuss the progress of the Centre, both organisational as well as scientifical. The Centre is a highly interdisciplinary organisation where researchers from academia, hospital and industry are collaborating towards the end goals. Examples of added value resulting from the Centre are the creation of biobanks, close interaction between medical doctors and academic researcher, and implementation of clinical research.